Switch theme
Sign up to access all valuation multiples
Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. Company operates in USA, Germany, Australia, Switzerland, and Sweden. Majority of revenue is from USA.
1999
136
LTM Revenue $2.7M
LTM EBITDA -$75.9M
$105M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Anteris Technologies Glb has a last 12-month revenue of $2.7M and a last 12-month EBITDA of -$75.9M.
In the most recent fiscal year, Anteris Technologies Glb achieved revenue of $1.7M and an EBITDA of -$46.9M.
Anteris Technologies Glb expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Anteris Technologies Glb valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.8M | $1.7M | XXX | XXX | XXX |
| Gross Profit | $1.1M | $1.1M | XXX | XXX | XXX |
| Gross Margin | 63% | 63% | XXX | XXX | XXX |
| EBITDA | -$28.3M | -$46.9M | XXX | XXX | XXX |
| EBITDA Margin | -1609% | -2761% | XXX | XXX | XXX |
| Net Profit | -$19.0M | -$28.8M | XXX | XXX | XXX |
| Net Margin | -1077% | -1697% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 25, 2025, Anteris Technologies Glb's stock price is AUD 7 (or $5).
Anteris Technologies Glb has current market cap of AUD 276M (or $174M), and EV of AUD 168M (or $105M).
See Anteris Technologies Glb trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $105M | $174M | XXX | XXX | XXX | XXX | $-3.29 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 25, 2025, Anteris Technologies Glb has market cap of $174M and EV of $105M.
Anteris Technologies Glb's trades at 39.6x LTM EV/Revenue multiple, and -1.4x LTM EBITDA.
Analysts estimate Anteris Technologies Glb's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Anteris Technologies Glb and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $105M | XXX | XXX | XXX |
| EV/Revenue | 62.1x | XXX | XXX | XXX |
| EV/EBITDA | -2.2x | XXX | XXX | XXX |
| P/E | -3.6x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -2.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAnteris Technologies Glb's NTM/LTM revenue growth is 73%
Anteris Technologies Glb's revenue per employee for the last fiscal year averaged $12K, while opex per employee averaged $0.4M for the same period.
Over next 12 months, Anteris Technologies Glb's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Anteris Technologies Glb's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Anteris Technologies Glb and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -3% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -2761% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 66% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -2687% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $12K | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.4M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 1043% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 1903% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 2994% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Anteris Technologies Glb acquired XXX companies to date.
Last acquisition by Anteris Technologies Glb was XXXXXXXX, XXXXX XXXXX XXXXXX . Anteris Technologies Glb acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Anteris Technologies Glb founded? | Anteris Technologies Glb was founded in 1999. |
| Where is Anteris Technologies Glb headquartered? | Anteris Technologies Glb is headquartered in Australia. |
| How many employees does Anteris Technologies Glb have? | As of today, Anteris Technologies Glb has 136 employees. |
| Is Anteris Technologies Glb publicy listed? | Yes, Anteris Technologies Glb is a public company listed on ASX. |
| What is the stock symbol of Anteris Technologies Glb? | Anteris Technologies Glb trades under AVR ticker. |
| When did Anteris Technologies Glb go public? | Anteris Technologies Glb went public in 2004. |
| Who are competitors of Anteris Technologies Glb? | Similar companies to Anteris Technologies Glb include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Anteris Technologies Glb? | Anteris Technologies Glb's current market cap is $174M |
| What is the current revenue of Anteris Technologies Glb? | Anteris Technologies Glb's last 12-month revenue is $2.7M. |
| What is the current EBITDA of Anteris Technologies Glb? | Anteris Technologies Glb's last 12-month EBITDA is -$75.9M. |
| What is the current EV/Revenue multiple of Anteris Technologies Glb? | Current revenue multiple of Anteris Technologies Glb is 39.6x. |
| What is the current EV/EBITDA multiple of Anteris Technologies Glb? | Current EBITDA multiple of Anteris Technologies Glb is -1.4x. |
| What is the current revenue growth of Anteris Technologies Glb? | Anteris Technologies Glb revenue growth between 2023 and 2024 was -3%. |
| Is Anteris Technologies Glb profitable? | Yes, Anteris Technologies Glb is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
